Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness
NCT02594696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2018-02-05
Summary
Individuals with severe mental illness (SMI) including schizophrenia and bipolar disorder are dying younger than the general population; cancer is a leading cause of death in this population. People with SMI have higher rates of dying from breast, lung, and colon cancer, and disparities in treatment appear to be one contributing factor. Individuals with SMI may be diagnosed with more advanced stage cancer and less likely to receive stage-appropriate cancer treatment. Although collaborative care models integrating medical and psychiatric care have shown promise in other populations, the challenge of treating SMI and cancer is distinct and relatively understudied. Patients may have uncontrolled psychiatric symptoms that can impact their understanding of their diagnosis and treatment decisions. Oncologists have less training and inadequate time to address multiple unmet needs. Mental health care is frequently fragmented from cancer care.
The investigators want to understand if it is helpful for patients with SMI to be connected to a psychiatrist and case manager when cancer is diagnosed. Optimizing psychiatric symptoms and facilitating communication between the patient, the oncology team, and mental health providers may improve care. The goal is to pilot a pragmatic intervention for patients with cancer and SMI that can be integrated into cancer care, is acceptable to patients and oncology clinicians, and may promote the delivery of stage-appropriate cancer treatment to an underserved population.
Patients will be connected to a psychiatrist and case manager at cancer diagnosis who will follow the patient and communicate with the oncology team during the 12 week intervention. All participants will complete brief surveys at baseline, 4 weeks, and 12 weeks. Oncology clinicians will provide feedback about the intervention at 12 weeks. Cancer treatment received and healthcare utilization will be assessed at 6 months post-intervention.
Conditions
Interventions
- OTHER
-
Proactive Psychiatry Consultation (PPC)
* The psychiatrist conducts a tailored, cancer-specific assessment to optimize psychiatric symptoms and collaborates with the oncologist to develop and modify the cancer treatment plan. * The case manager, a social worker, engages with the patient to promote self-management, identify and address barriers to care, and bridge communication with oncology and mental health. * The psychiatrist and case manager proactively monitor symptoms and the process of cancer care, remain in regular contact with the patient and communicate with the oncology team at least every 4 weeks * The psychiatrist and case manager are available for consultation across care settings (outpatient, inpatient, home). * Recommendations are documented in the medical record and communicated directly to the oncology team
Sponsors & Collaborators
-
American Cancer Society, Inc.
collaborator OTHER -
National Cancer Institute (NCI)
collaborator NIH -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Kelly Irwin, MD · Massachusetts General Hospital
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-09
- Primary Completion
- 2016-07-21
- Completion
- 2017-11-01
Countries
- United States
Study Locations
More Related Trials
-
The Management of Schizophrenia in Clinical Practice (MOSAIC)
NCT01746134 ·Status: COMPLETED
-
Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
NCT01907282 ·Status: COMPLETED ·Phase: NA
-
Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia
NCT05498571 ·Status: UNKNOWN
-
Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People
NCT00169052 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
NCT02086162 ·Status: COMPLETED ·Phase: NA
-
Study of Pharmacotherapy of Psychotic Depression
NCT00056472 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic
NCT06624462 ·Status: RECRUITING ·Phase: NA
-
Impact of Genetic Counseling for Individuals With Mental Illness
NCT00713804 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of the Use of a New Physical Health Plan
NCT03178279 ·Status: COMPLETED ·Phase: NA
-
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
NCT00569504 ·Status: UNKNOWN
-
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
NCT04940663 ·Status: RECRUITING ·Phase: NA
-
Enhancing the Prospective Prediction of Psychosis
NCT00291200 ·Status: COMPLETED
-
Inpatient Evaluation of Adults With Schizophrenia
NCT00001247 ·Status: COMPLETED
-
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population
NCT00253240 ·Status: COMPLETED
-
Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness
NCT00500695 ·Status: COMPLETED ·Phase: PHASE1
-
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003 ·Status: ACTIVE_NOT_RECRUITING
-
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770 ·Status: UNKNOWN
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
Reducing the Weight of Overweight Schizophrenia Patients
NCT00158366 ·Status: COMPLETED ·Phase: NA
-
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
NCT02019459 ·Status: COMPLETED ·Phase: PHASE2
-
Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight
NCT00584519 ·Status: COMPLETED
-
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
NCT01215383 ·Status: UNKNOWN
-
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder
NCT00382915 ·Status: COMPLETED
-
Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
NCT06807242 ·Status: COMPLETED
-
Improving Accessibility and Personalization of CR for Schizophrenia
NCT03576976 ·Status: COMPLETED ·Phase: NA